Article
Novo Nordisk: 80% of U.S. Wegovy patients with insurance paying less than $25/month
Rating:
0.0
Views:
57
Likes:
1
Library:
1
The majority of U.S. patients with health insurance coverage taking Novo Nordisk's powerful weight-loss drug Wegovy are paying less than $25 per month, a senior executive said on Thursday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value